Nextech Invest »

Monte Rosa Therapeutics shares owned by Nextech Invest

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Nextech Invest from 13F filings

Historical chart of Nextech Invest investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Nextech Invest consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Nextech Invest

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.4M 279k 15.68

More positions owned by Nextech Invest

Revolution Medicines (RVMD)
Tyra Biosciences (TYRA)
Tango Therapeutics (TNGX)
Oric Pharmaceuticals (ORIC)
Relay Therapeutics (RLAY)
Zymeworks Del (ZYME)
Alumis (ALMS)
Kymera Therapeutics (KYMR)
Engene Holdings (ENGN)
Mersana Therapeutics (MRSN)
Cullinan Oncology (CGEM)
Context Therapeutics (CNTX)
Silverback Therapeutics (SPRY)
Arvinas Ord (ARVN)
Silence Therapeutics Ads (SLN)

View all positions for Nextech Invest

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Baker Bros. Advisors
TCG Crossover Management
Versant Venture Management
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
State Street Corporation
Aisling Capital Management
American Century Companies
Geode Capital Management
MPM Oncology Impact Management
Silverarc Capital Management

View all funds holding Monte Rosa Therapeutics